Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ F Bd+=bx,Z
Y j,9V],
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ^!zJf7(+<>
>$d d9|[
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© wWp?HDl"M
.&aVx]
1.Co-stimulators (or co-stimulating molecules) p{('KE)
]9!Gg
2.NK-kB PW(_yB;
gDUoc*+h
3.Immunoglobulin superfamily ]~4}(\u
$~;6 hnrm
4.antigen-presenting cell (APC) ?STI8AdO
>d1aE)?
5.death domain 1t
uator
x3:ZB
6.CCR and CXCR AZBY, :>D
)%-\hl]
7.Lectin (or mitogen) ^@l5u=
K~9 jin
8.Clusters of differentiation, CD) 1{Sx V
A=@V LU4%
9.B7 family 7ZR0M&pX
\dQ2[Ek
10.Cytotoxic T lymphocyte, CTL) Tk2&{S "
a*e|>p DO
11.IL-15 and IL-15 receptor (IL-15R) v@<lEG#$"|
pB{ f-M:D
12.MHC restriction QjT#GvHY
iI/'!85
13.Affinity-chromatography & t @
<jg
wdbT"6
14.Cyctosprin A, CsA 'j=PbA
Phjf$\pt
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) p-ii($~}
]'z^Kt5S
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 22H=!.DJ
<=LsloI
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 '@1Q
x~*]e
RdpQJ)3F
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ >G -?e!
G5Dji_ |
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ I.n{ "=$B@
Fb`7aFIf
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© V3Rnr8
F$pd]F!#
ÃâÒßѧרҵ£º `5aypJf1
~O3uje
_
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ mZ.6Njb
,t,65@3+b
Ïû»¯ÄÚ¿Æ£º X+G*Q}5
?.'oxW
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ,)\5O0 D6
L.~]qs|G/K
ѪҺ²¡Ñ§×¨Òµ£º F[qIfh4
C{Xk/Er5<
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿